| Sanofi-Aventis (Suisse) SA - Pentavac, Poudre et suspension pour suspension injectable | | 00613 | | 01 | | Pentavac | | Poudre et suspension pour suspension injectable | | J07CA06 | | Diphtheria-Haemophilus Influenzae B-Pertussis-Poliomyelitis-Tetanus | | 18.08.1999 | | |
| | Composition | | I) composant DPTa-IPV (suspension): toxoidum diphtheriae min. 20 U.I., toxoidum tetani min. 40 U.I., bordetellae pertussis antigenum: toxoidum pertussis 25 µg et haemagglutininum filamentosum 25 µg, virus poliomyelitis typus 1 inactivatus 29 U., virus poliomyelitis typus 2 inactivatus 7 U., virus poliomyelitis typus 3 inactivatus 26 U., aluminium 0.3 mg ut aluminii hydroxidum hydricum ad adsorptionem, formaldehydum, medium 199 cum phenylalaninum 12.5 µg et kalium, acidum aceticum glaciale q.s. ad pH, natrii hydroxidum q.s. ad pH, phenoxyethanolum, ethanolum anhydricum 2 mg, aqua ad iniectabile q.s. ad suspensionem pro 0.5 ml, residui: neomycinum, streptomycinum, polymyxinum B nihil.
II) composant Hib (poudre): polysaccharida haemophili influenzae typus B 1482 conjugata cum toxoido tetani 10 µg, trometamolum, saccharum, acidum hydrochloridum q.s. ad pH, pro praeparatione. | | Packungsbestandteile | | II | | | suspension injectable et lyophilisat | | | | | | | | | BAG: Active Agent | Dose |
|---|
| Haemophilus Influenzae b Polysaccharida (Prp) | 10 mcg | | Toxoidum Diphtheriae | 20 UI | | Toxoidum Pertussis | 25 mcg | | Toxoidum Tetani | 40 UI | | Vaccinum Poliomyelitidis Inactivatum (Salk typ I, II, III) | 62 U |
| | | | Inactive agents | Dose |
|---|
| Acidum Hydrochloridum | | | Composant hib (Poudre): Polysaccharida Haemophili Influenzae Typus B | 1482 | | Conjugata cum Toxoido Tetani | 10 µg | | Saccharum | | | Trometamol | |
| |
| I | | | Poudre et suspension pour suspension injectable | | | | | | | | Active Agent | Dose |
|---|
| Composant Dpta-Ipv (Suspension): Toxoidum Diphtheriae | 20 UI | | Toxoidum Tetani | 40 UI |
| | BAG: Active Agent | Dose |
|---|
| Haemophilus Influenzae b Polysaccharida (Prp) | 10 mcg | | Toxoidum Diphtheriae | 20 UI | | Toxoidum Pertussis | 25 mcg | | Toxoidum Tetani | 40 UI | | Vaccinum Poliomyelitidis Inactivatum (Salk typ I, II, III) | 62 U |
| | | | Inactive agents | Dose | additional_information |
|---|
| Acidum Aceticum Glaciale | | | | Alumine | 0.3 mg | | | Cum Phenylalaninum | 12.5 µg | | | Formaldehydum | | | | Haemagglutininum Filamentosum | 25 µg | | | Inactivatus | 26 U | | | Potassium | | | | Medium | 199 | | | Toxoidum Pertussis | 25 µg | bordetellae pertussis antigenum | | Virus Poliomyelitis Typus | 3 | |
| |
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | Durchstechflasche(n) | 34.19 | 53.60 | B | SL | Yes |
|
|
